22-43540207-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_022785.4(EFCAB6):c.3799G>A(p.Val1267Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000184 in 1,614,108 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_022785.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EFCAB6 | NM_022785.4 | c.3799G>A | p.Val1267Ile | missense_variant | 28/32 | ENST00000262726.12 | NP_073622.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EFCAB6 | ENST00000262726.12 | c.3799G>A | p.Val1267Ile | missense_variant | 28/32 | 2 | NM_022785.4 | ENSP00000262726 | P1 | |
EFCAB6 | ENST00000396231.6 | c.3343G>A | p.Val1115Ile | missense_variant | 26/30 | 1 | ENSP00000379533 | |||
EFCAB6 | ENST00000461800.5 | n.436G>A | non_coding_transcript_exon_variant | 3/7 | 1 | |||||
EFCAB6-AS1 | ENST00000656483.1 | n.249-18410C>T | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152230Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000143 AC: 36AN: 251458Hom.: 0 AF XY: 0.000184 AC XY: 25AN XY: 135906
GnomAD4 exome AF: 0.000194 AC: 284AN: 1461878Hom.: 0 Cov.: 31 AF XY: 0.000187 AC XY: 136AN XY: 727242
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152230Hom.: 0 Cov.: 33 AF XY: 0.0000941 AC XY: 7AN XY: 74376
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 15, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at